GlassScriptPhysician profile
Anaeis Hambarsoomian
NPI 1912696725
$4,020.69
in general payments reported to CMS, 2019-2025
21 companies · $1,654 in 2025
The $1,654 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $274 · 2024: $2,093 · 2025: $1,654.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,931 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,930.69 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $882.51 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $766.21 | 2023-2025 | |
| Glaxosmithkline, LLC. | $530.46 | 2023-2025 | Benlysta |
| Amgen INC. | $470.81 | 2023-2025 | Enbrel, Otezla, Enbrel |
| Janssen Biotech, INC. | $442.85 | 2023-2025 | Tremfya |
| Astrazeneca Pharmaceuticals LP | $164.20 | 2023-2025 | Saphnelo |
| E.R. Squibb & Sons, L.L.C. | $143.32 | 2024-2025 | Orencia |
| Ucb, INC. | $126.73 | 2024-2025 | Bimzelx, Cimzia |
| Mallinckrodt Hospital Products INC. | $93.02 | 2024 | Acthar |
| Kiniksa Pharmaceuticals International, Plc | $72.67 | 2024 | Arcalyst |
| Alexion Pharmaceuticals, INC. | $58.81 | 2025 | Strensiq |
| Genentech USA, INC. | $38.32 | 2024 | Actemra |
| Aurinia Pharma U.S., INC. | $36.17 | 2024-2025 | Lupkynis |
| Fresenius Kabi USA, LLC | $33.87 | 2024 | Tyenne |
| Sobi, INC | $31.81 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $25.00 | 2023 | Arcalyst |
| Ani Pharmaceuticals, INC. | $24.08 | 2024 | Purified Cortrophin Gel |
| Zimmer Biomet Holdings, INC. | $24.04 | 2023 | Gel-One Cross-Linked Hyaluronate |
| Radius Health, INC. | $24.02 | 2025 | |
| Bioventus LLC | $17.13 | 2024 | Durolane |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.66 | 2024 | Cyltezo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anaeis Hambarsoomian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.